热毒宁通过拮抗病毒NS1蛋白抑制宿主I型干扰素信号发挥抗流感作用
热毒宁注射液是临床用于流感高热等证的现代中药制剂,但其抗甲型流感病毒(IAV)作用存在争议。本研究在小鼠体内外评价热毒宁抗IAV效果并探讨机制,发现其可降低死亡率、肺指数和病毒载量,部分通过减弱NS1与JAK1/TYK2关联、恢复IFN-I-JAK/STAT-ISG信号,绿原酸为主要活性成分之一。
要点
- 热毒宁注射液可降低IAV感染小鼠死亡率、肺指数和病毒载量,减轻肺损伤。
- 热毒宁部分恢复宿主IFN-I-JAK/STAT-ISG抗病毒信号,可能通过减弱NS1-JAK1/TYK2关联。
- 绿原酸是热毒宁抗NS1活性的主要贡献成分之一,可减弱NS1-JAK1关联。
核心结论
- 热毒宁注射液具有显著抗IAV活性,可部分恢复宿主IFN-I-JAK/STAT-ISG抗病毒信号,可能通过减弱NS1-JAK1/TYK2关联实现。
- 绿原酸被鉴定为热毒宁抗NS1活性的主要贡献成分之一。
研究设计与样本
- 研究采用小鼠IAV感染模型评估热毒宁抗病毒效果,监测死亡率、体重、肺指数、肺病毒载量和组织病理变化。
- 采用qRT-PCR和Western blotting定量体内IFN-α/β及ISG15、MX1、OAS1、PKR,并评估IFNAR1/IFNAR2-JAK1/TYK2-STAT1/STAT2通路活化。
- 采用siRNA敲低STAT1或STAT2考察其对热毒宁抗病毒作用的影响。
- 采用ISRE-荧光素酶报告基因、磷酸化检测、核转位及NS1相关蛋白复合物评估NS1对IFN-I信号的影响及热毒宁的抑制作用。
- 采用HPLC和HPLC-Q-TOF-MS/MS鉴定热毒宁及其极性部位峰成分,结合谱效关系分析鉴定抗NS1成分并验证。
主要发现
- 热毒宁对IAV感染小鼠提供显著保护,降低死亡率、减轻体重丢失、降低肺指数和病毒载量、减轻肺损伤。
- 感染后RDN(H)组IFN-α/β表达持续低于模型组;感染后第1、2天RDN(H)组ISG15、MX1、OAS1、PKR与模型组相当,第4天ISG15和MX1明显升高。
- RDN(H)组STAT1和STAT2磷酸化在第4天相对模型组短暂升高。
- siRNA敲低STAT1或STAT2可降低但不能消除热毒宁的抗IAV活性。
- 热毒宁剂量依赖性抑制NS1(A/Puerto Rico/8/34,PR8)介导的ISRE-荧光素酶活性抑制。
临床怎么用
- 热毒宁注射液临床用于流感相关高热和上呼吸道感染,具有已验证的临床疗效和良好安全性。
- 本研究提示热毒宁抗IAV作用与部分恢复宿主IFN-I-JAK/STAT-ISG信号及拮抗NS1功能相关,为宿主导向抗病毒策略提供机制依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Re Du Ning (RDN) injection is a modern Chinese herbal formulation with heat-clearing, wind-dispersing, and detoxifying properties. It is clinically used for the treatment of influenza-related high fever and upper respiratory tract infections, with validated clinical efficacy and a favorable safety profile. Although its anti-inflammatory activity has been extensively documented, the antiviral effects of RDN against influenza A virus (IAV) remain controversial, and the underlying mechanisms are not fully elucidated. AIM OF THE STUDY: To investigate the mechanisms and active constituents through which RDN exerts anti-influenza activity by counteracting viral nonstructural protein 1 (NS1)-mediated suppression of host type I interferon (IFN-I) signaling. MATERIALS AND METHODS: The anti-IAV efficacy of RDN was evaluated by monitoring mortality, body weight, lung index, pulmonary viral load, and histopathological changes. qRT-PCR and Western blotting were used to quantify IFN-α/β and interferon-stimulated genes (ISG15, MX1, OAS1, and PKR) at defined time points in vivo, as well as to assess the activation of the IFNAR1/IFNAR2-JAK1/TYK2-STAT1/STAT2 signaling pathway. The contribution of STAT1 and STAT2 to the antiviral effects of RDN was examined using siRNA-mediated knockdown. The effects of NS1 on IFN-I signaling and the inhibitory role of RDN were assessed by evaluating interferon-stimulated response element (ISRE)-luciferase reporter activation, JAK1/TYK2-STAT1/STAT2 phosphorylation, STAT1/STAT2 nuclear translocation, and NS1-associated protein complexes. Chromatographic profiles of RDN and its polarity fractions were obtained by HPLC, and peak constituents were identified by HPLC-Q-TOF-MS/MS. Anti-NS1 constituents were identified using spectrum-effect relationship analysis and subsequently validated. RESULTS: RDN provided significant protection against IAV infection in mice, reducing mortality, attenuating body weight loss, lowering lung index and viral load, and alleviating lung injury. After infection, IFN-α/β expression remained consistently lower in the RDN (H) group than in the model group. In contrast, ISG15, MX1, OAS1, and PKR levels in the RDN (H) group were comparable to those in the model group on days 1 and 2 post-infection, whereas ISG15 and MX1 were markedly elevated on day 4. Consistently, STAT1 and STAT2 phosphorylation was transiently increased on day 4 relative to the model group. siRNA-mediated knockdown of STAT1 or STAT2 reduced, but did not abolish, the anti-IAV activity of RDN. RDN dose-dependently inhibited NS1 (A/Puerto Rico/8/34, PR8)-mediated suppression of ISRE-luciferase activity. NS1 suppressed phosphorylation of JAK1, TYK2, STAT1, and STAT2 and impaired STAT1/STAT2 nuclear translocation. RDN mitigated NS1-mediated suppression of STAT1 and STAT2 phosphorylation and nuclear translocation both in vitro and in vivo. No detectable association was observed between NS1 and either exogenously expressed STAT1 or STAT2; however, NS1 was found to associate with exogenously expressed JAK1 and TYK2, and these associations were attenuated by RDN. Chlorogenic acid was identified as one of the major contributing constituents that weakened the NS1-JAK1 association and mitigated NS1-mediated suppression of STAT1/STAT2 phosphorylation. By contrast, neochlorogenic acid alleviated NS1-mediated inhibition of STAT1 phosphorylation but did not significantly affect NS1-JAK1 or NS1-TYK2 associations. CONCLUSIONS: This study demonstrates that RDN exerts significant anti-IAV activity. JAK1 and TYK2 may be previously underappreciated host kinases associated with PR8 NS1. RDN partially restored host IFN-I-JAK/STAT-ISG antiviral signaling, potentially by attenuating NS1-JAK1/TYK2 associations. Chlorogenic acid was identified as one of the major constituents contributing to the anti-NS1 activity of RDN. These findings provide mechanistic insight into the host-directed antiviral activity of RDN.
引用
- Ke S, Chen R, Wang J, et al. Re Du Ning exerts anti-influenza activity by counteracting viral NS1-mediated suppression of host type I interferon signaling. J Ethnopharmacol. 2026. PMID: 42235715. doi:10.1016/j.jep.2026.121952
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。